It is also indicated that the aberrant overexpression of MALAT1 is associated with WHO glioma grade significantly (I–II vs. III–IV; P = 0.007) and with glioma size (<3 cm vs. T ≥ 3 cm; P = 0.008). The gene discussed is MALAT1; the disease is central nervous system cancer.